Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of PCSO-524 in the Treatment of Canine Osteoarthritis
TCTR20160105003Phase 2Not yet recruiting
- Sponsor
- Pharmalink International
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PCSO-524 in osteoarthritis (OA), sponsored by Pharmalink International. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
PCSO-524
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on TCTR20160105003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160105003.